OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AIDR.CD58

Rocket Doctor AI Inc

Advanced Medical Equipment & TechnologyVerified

Rocket Doctor AI Inc has a current ratio of 1.8, indicating moderate liquidity, but its operating cash flow of -841,000 CAD suggests ongoing cash outflows from operations. The company's debt-to-equity ratio of 0.46 reflects a relatively conservative capital structure, with long-term debt of 561,300 CAD compared to total equity of 1,209,380 CAD. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The company's profitability metrics are negative, with a return on equity of -76.62% and a return on assets of -34.03%, indicating significant underperformance relative to its equity and asset base. These figures suggest that the company is not generating returns that justify its capital investment and is likely operating at a loss. Rocket Doctor AI Inc does not disclose segment or geographic revenue data in the provided financials, so it is not possible to assess revenue concentration or geographic exposure. This lack of detail limits the ability to evaluate the company's diversification and potential regional risks. The company's revenue is reported as 0 CAD, and there is no historical revenue data provided to assess growth trajectory. Analysts have assigned a mean price target of 2.10 CAD, with a mean recommendation of 2.00 (indicating a "Buy" rating), but there are no strong-buy recommendations. The absence of revenue and growth data makes it difficult to determine the company's future performance. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag, suggesting potential challenges in meeting short-term obligations. No dilution sources are explicitly identified in the provided data, and the dilution risk is assessed as low. There are no recent events, filings, or transcripts provided in the input data to inform the company's current operational or strategic developments. This lack of recent information limits the ability to assess the company's current direction or any material changes in its business.

30-day price · AIDR.CD+0.01 (+1.8%)
Low$0.54High$0.72Close$0.58As of16 May, 00:00 UTC
Profile
CompanyRocket Doctor AI Inc
TickerAIDR.CD
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. Rocket Doctor AI Inc is a healthcare technology company that provides AI-driven diagnostic and treatment solutions for medical professionals.

Classification. Rocket Doctor AI Inc is classified under the Healthcare sector, specifically in the Advanced Medical Equipment & Technology industry, with a classification confidence of 0.92.

Rocket Doctor AI Inc has a current ratio of 1.8, indicating moderate liquidity, but its operating cash flow of -841,000 CAD suggests ongoing cash outflows from operations. The company's debt-to-equity ratio of 0.46 reflects a relatively conservative capital structure, with long-term debt of 561,300 CAD compared to total equity of 1,209,380 CAD. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The company's profitability metrics are negative, with a return on equity of -76.62% and a return on assets of -34.03%, indicating significant underperformance relative to its equity and asset base. These figures suggest that the company is not generating returns that justify its capital investment and is likely operating at a loss. Rocket Doctor AI Inc does not disclose segment or geographic revenue data in the provided financials, so it is not possible to assess revenue concentration or geographic exposure. This lack of detail limits the ability to evaluate the company's diversification and potential regional risks. The company's revenue is reported as 0 CAD, and there is no historical revenue data provided to assess growth trajectory. Analysts have assigned a mean price target of 2.10 CAD, with a mean recommendation of 2.00 (indicating a "Buy" rating), but there are no strong-buy recommendations. The absence of revenue and growth data makes it difficult to determine the company's future performance. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The negative net cash position after subtracting total debt is a key flag, suggesting potential challenges in meeting short-term obligations. No dilution sources are explicitly identified in the provided data, and the dilution risk is assessed as low. There are no recent events, filings, or transcripts provided in the input data to inform the company's current operational or strategic developments. This lack of recent information limits the ability to assess the company's current direction or any material changes in its business.
Key takeaways
  • Rocket Doctor AI Inc has a negative return on equity and return on assets, indicating poor profitability.
  • The company's liquidity is moderate, but its negative operating cash flow and negative net cash position after debt suggest potential liquidity constraints.
  • Analysts have assigned a "Buy" rating with a mean price target of 2.10 CAD, but there are no strong-buy recommendations.
  • The company's capital structure is relatively conservative, with a debt-to-equity ratio of 0.46.
  • No segment or geographic revenue data is available, limiting the ability to assess diversification and regional exposure.
  • The company's revenue is reported as 0 CAD, and there is no historical data to assess growth trajectory.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCAD
Revenue$0.00
Gross profit
Operating income-$925.4k
Net income-$926.6k
R&D
SG&A
D&A
SBC
Operating cash flow-$841.0k
CapEx
Free cash flow
Total assets$2.7M
Total liabilities$1.5M
Total equity$1.2M
Cash & equivalents
Long-term debt$561.3k
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4-$13.8M-$13.9M
FY-3-$3.8M-$3.8M
FY-2-$3.9M-$3.7M
FY-1$11.0k-$7.5M-$7.6M
FY0$1.7M-$13.3M-$15.7M-$14.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$942.5k$109.9k
FY-3$13.7k-$2.2M
FY-2$739.3k-$738.0k
FY-1$1.3M$792.8k
FY0$10.6M$3.5M
PeriodOCFCapExFCFSBC
FY-4-$6.3M
FY-3-$1.5M
FY-2-$740.1k
FY-1-$4.4M
FY0-$6.6M-$6.6k-$14.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$0.00-$925.4k-$926.6k
FQ-6-$2.7M-$2.7M
FQ-5$11.0k-$1.2M-$1.7M
FQ-4$0.00-$2.7M-$2.3M
FQ-3-$2.1M-$2.1M
FQ-2$512.8k-$2.8M-$2.7M-$2.7M
FQ-1$529.1k-$3.0M-$3.5M-$3.5M
FQ0$697.3k-$5.5M-$7.3M-$5.8M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$2.7M$1.2M
FQ-6$1.0M$370.6k
FQ-5$883.3k$322.9k
FQ-4$1.3M$792.8k
FQ-3$3.2M$2.3M
FQ-2$18.5M$8.1M
FQ-1$20.4M$9.9M
FQ0$10.6M$3.5M
PeriodOCFCapExFCFSBC
FQ-7-$841.0k
FQ-6-$2.2M
FQ-5-$3.5M
FQ-4-$4.4M
FQ-3-$1.6M
FQ-2-$2.8M-$2.7M
FQ-1-$4.9M-$3.1k-$3.5M
FQ0-$6.6M-$6.6k-$5.8M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.2M
Net cash-$561.3k
Current ratio1.8
Debt/Equity0.5
ROA-34.0%
ROE-76.6%
Cash conversion91.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Equipment · cohort 91 companies
MetricAIDR.CDActivity
Op margin-16.5% medp25 -174.5% · p75 8.8%
Net margin-16.5% medp25 -172.4% · p75 8.4%
Gross margin47.4% medp25 34.2% · p75 65.3%
CapEx / revenue-5.4% medp25 -12.5% · p75 -2.2%
Debt / equity46.0%4.3% medp25 0.0% · p75 28.0%top quartile
Observations
IR observations
Mean price target2.10 CAD
Median price target2.10 CAD
High price target2.10 CAD
Low price target2.10 CAD
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-0.13 CAD
Mean revenue estimate1,614,268,000 CAD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 01:36 UTC#e7a1c65f
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 07:16 UTCJob: 0f9d376c